| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1393446 | European Journal of Medicinal Chemistry | 2008 | 7 Pages |
Abstract
Novel B1 antagonist core 1,2,3,4-tetrahydroisoquinolin-1-ylacetic acid was utilized and the effect of modification of its amide side chain on the biological activity was tested.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
József Huszár, Zoltán Timár, Krisztina Katalin Szalai, György Keserű, Ferenc Fülöp, Botond Penke,